Singapore Home Infusion Therapy Market Size & Outlook

The home infusion therapy market in Singapore is expected to reach a projected revenue of US$ 299.9 million by 2030. A compound annual growth rate of 8.8% is expected of Singapore home infusion therapy market from 2024 to 2030.
Revenue, 2023 (US$M)
$165.9
Forecast, 2030 (US$M)
$299.9
CAGR, 2024 - 2030
8.8%
Report Coverage
Singapore

Singapore home infusion therapy market, 2018-2030 (US$M)

Singapore

Related Markets

Singapore home infusion therapy market highlights

  • The Singapore home infusion therapy market generated a revenue of USD 165.9 million in 2023 and is expected to reach USD 299.9 million by 2030.
  • The Singapore market is expected to grow at a CAGR of 8.8% from 2024 to 2030.
  • In terms of segment, anti-infective was the largest revenue generating application in 2023.
  • Endocrinology is the most lucrative application segment registering the fastest growth during the forecast period.


Home infusion therapy market data book summary

Market revenue in 2023USD 165.9 million
Market revenue in 2030USD 299.9 million
Growth rate8.8% (CAGR from 2023 to 2030)
Largest segmentAnti-infective
Fastest growing segmentEndocrinology
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationAnti-Infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals
Key market players worldwideCVS Group PLC, Walgreens Boots Alliance Inc, UnitedHealth Group Inc, BrightSpring Health Services Inc, Fresenius Medical Care AG, ICU Medical Inc, B. Braun Medical, Baxter International Inc, BD, Smiths Group PLC, Terumo Corp, Caesarea Medical Electronics


Other key industry trends

  • In terms of revenue, Singapore accounted for 0.5% of the global home infusion therapy market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, Japan home infusion therapy market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 2,171.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Home Infusion Therapy Market Companies

Name Profile # Employees HQ Website

Singapore home infusion therapy market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to home infusion therapy market will help companies and investors design strategic landscapes.


Anti-infective was the largest segment with a revenue share of 26.76% in 2023. Horizon Databook has segmented the Singapore home infusion therapy market based on anti-infective, endocrinology, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals covering the revenue growth of each sub-segment from 2018 to 2030.


According to World Bank Group, the country’s population aged 65 & above accounted for nearly 10.6% of the total population in 2017 and around 12.4% in 2019. Furthermore, according to Cable News Network, by 2030, around 20.5% of the country’s population is estimated to be aged above 65. The rise in geriatric population is anticipated to increase the demand for long-term and home care services, thereby fueling the market growth. The Home Nursing Foundation (Singapore) funded nearly 4,500 patients in 2016 in comparison with 4,050 patients in 2015. 

In addition, funds such as the Seniors' Mobility and Enabling Fund (SMF) focus on providing subsidies to Singaporean senior citizens to receive home-based care. Such factors are boosting the market growth in the country. However, home-care services in the country are mainly funded by the private sector and/or NGOs, which have limited subsidies, thus home-care services are still relatively expensive, thereby limiting access to and affordability of these services for majority of the people in Singapore, especially those covered under public insurance Medisave.

Reasons to subscribe to Singapore home infusion therapy market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Singapore home infusion therapy market databook

  • Our clientele includes a mix of home infusion therapy market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Singapore home infusion therapy market , including forecasts for subscribers. This country databook contains high-level insights into Singapore home infusion therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Singapore home infusion therapy market size, by application, 2018-2030 (US$M)

Singapore Home Infusion Therapy Market Outlook Share, 2023 & 2030 (US$M)

Singapore home infusion therapy market size, by application, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more